DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

BPLPHARMA vs ZOTA: Stock Comparison

BHARAT PARENTERALS vs ZOTA HEALTH CAREUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. BHARAT PARENTERALS shows a higher dividend yield and a higher net margin, while ZOTA HEALTH CARE shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BPLPHARMA leads 6; ZOTA leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BPLPHARMAZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹1,278 Cr
₹4,270 Cr
P/E RatioZOTA has the lower reading
1,029.83x
0x ✓
P/B RatioBPLPHARMA has the lower reading
3.85x ✓
6.83x
EPSBPLPHARMA has the higher reading
₹13.66 ✓
₹-7.39
Book ValueContext only
₹452.09
₹201.01
Dividend YieldBPLPHARMA has the higher reading
0.05% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹4,270 Cr vs ₹1,278 Cr
P/E Ratio
ZOTA has a lower P/E
0x vs 1,029.83x
P/B Ratio
BPLPHARMA has a lower P/B
3.85x vs 6.83x
EPS
BPLPHARMA has higher earnings per share
₹13.66 vs ₹-7.39
Dividend Yield
BPLPHARMA has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
BPLPHARMA has stronger quarterly sales growth
45.39% vs 14.82%
Qtr Profit Growth
BPLPHARMA has stronger quarterly profit growth
431.7% vs 40.93%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBPLPHARMAZOTA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricBPLPHARMAZOTA
Live Price₹1,881.9₹1,231.1
Day Change3.46%1.01%
Volume5,81230,294
52-Week High₹2,295.1₹1,740
52-Week Low₹1,125.7₹1,022
Distance from 52W High-18%-29.25%

Valuation

MetricBPLPHARMAZOTA
Market Cap₹1,278 Cr₹4,270 Cr
P/E Ratio1,029.83x0x
P/B Ratio3.85x6.83x
EPS₹13.66₹-7.39
Book Value₹452.09₹201.01
Dividend Yield0.05%0%

Growth

MetricBPLPHARMAZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth45.39%14.82%
Qtr Profit Growth431.7%40.93%

Profitability & Leverage

MetricBPLPHARMAZOTA
ROE—-10.64%
ROCE—-8.71%
Net Margin0%-13.98%
Operating Margin—-11.6%
Debt to Equity—0.04x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBPLPHARMAZOTA
Promoter Holding67.2%▲ 0.03 pp49.38%
FII Holding0.11%6.92%▼ 1 pp
DII Holding1.37%▲ 0.31 pp7.3%▲ 0.55 pp
Public Holding31.31%▼ 0.35 pp36.4%▲ 0.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BHARAT PARENTERALS and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.